The use of artificial intelligence in health care is exploding. Hospitals, drug companies and researchers are racing to make use of its newest iterations, but rapid adoption is outpacing our ability to separate hype from real progress.

In our latest webinar, STAT national correspondent Casey Ross breaks down the areas where artificial intelligence is making a difference and where empty promises are threatening to stifle progress. He also discusses the companies operating on this frontier and the tensions between profit motives, privacy, and the need to demonstrate benefits for patients.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy